Visual and Refractive Outcomes After Laser Blended Vision (PRESBYOND) in Patients With Myopia and Hyperopia.

IF 3 3区医学 Q1 OPHTHALMOLOGY

Journal of refractive surgery Pub Date : 2025-10-01 DOI:10.3928/1081597X-20250805-04

Anton Van Heerden, Deus Bigirimana

{"title":"Visual and Refractive Outcomes After Laser Blended Vision (PRESBYOND) in Patients With Myopia and Hyperopia.","authors":"Anton Van Heerden, Deus Bigirimana","doi":"10.3928/1081597X-20250805-04","DOIUrl":null,"url":null,"abstract":"Purpose: To report visual and refractive outcomes after treatment with PRESBYOND Laser Blended Vision (Carl Zeiss Meditec AG) using non-linear aspheric profiles combined with micro-anisometropia laser in situ keratomileusis (LASIK) for the correction of myopic and hyperopic presbyopia.Methods: This was a retrospective analysis of patients treated binocularly with PRESBYOND Laser Blended Vision using the MEL-90 excimer laser and VisuMax femtosecond laser (Carl Zeiss Meditec AG), and with at least 3-month postoperative data. Dominant eyes were targeted for plano and non-dominant eyes were targeted for myopia between -0.50 and -1.50 diopters (D). Manifest refraction, monocular and binocular uncorrected distance visual acuity (UDVA), monocular corrected distance visual acuity (CDVA), and binocular uncorrected near visual acuity were measured.Results: The study included 232 eyes of 116 patients (170 hyperopic eyes and 62 myopic eyes). In the hyperopic group, mean spherical equivalent (SEQ) was reduced from +1.49 ± 0.67 D preoperatively to -0.06 ± 0.39 D postoperatively in dominant eyes, and to -1.29 ± 0.57 D in non-dominant eyes, with 96.5% of eyes within ±1.00 D of target. Binocularly, mean UDVA was -0.06 ± 0.08 logarithm of the minimum angle of resolution (logMAR) with 90.5% of patients 20/20 or better at distance and 98.8% reading N8 or better. In the myopic group, mean SEQ was reduced from -4.52 ± 2.28 D preoperatively to +0.12 ± 0.49 D postoperatively in dominant eyes and to -1.04 ± 0.54 D in non-dominant eyes, with 96.8% of eyes within ±1.00 D of target. Binocularly, mean UDVA was -0.07 ± 0.09 logMAR with 87.1% of patients 20/20 or better at distance and 87.1% reading N8 or better.Conclusions: PRESBYOND Laser Blended Vision was a safe and effective procedure for the treatment of myopic and hyperopic presbyopia.","PeriodicalId":16951,"journal":{"name":"Journal of refractive surgery","volume":"41 10","pages":"e1089-e1097"},"PeriodicalIF":3.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of refractive surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3928/1081597X-20250805-04","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To report visual and refractive outcomes after treatment with PRESBYOND Laser Blended Vision (Carl Zeiss Meditec AG) using non-linear aspheric profiles combined with micro-anisometropia laser in situ keratomileusis (LASIK) for the correction of myopic and hyperopic presbyopia.

Methods: This was a retrospective analysis of patients treated binocularly with PRESBYOND Laser Blended Vision using the MEL-90 excimer laser and VisuMax femtosecond laser (Carl Zeiss Meditec AG), and with at least 3-month postoperative data. Dominant eyes were targeted for plano and non-dominant eyes were targeted for myopia between -0.50 and -1.50 diopters (D). Manifest refraction, monocular and binocular uncorrected distance visual acuity (UDVA), monocular corrected distance visual acuity (CDVA), and binocular uncorrected near visual acuity were measured.

Results: The study included 232 eyes of 116 patients (170 hyperopic eyes and 62 myopic eyes). In the hyperopic group, mean spherical equivalent (SEQ) was reduced from +1.49 ± 0.67 D preoperatively to -0.06 ± 0.39 D postoperatively in dominant eyes, and to -1.29 ± 0.57 D in non-dominant eyes, with 96.5% of eyes within ±1.00 D of target. Binocularly, mean UDVA was -0.06 ± 0.08 logarithm of the minimum angle of resolution (logMAR) with 90.5% of patients 20/20 or better at distance and 98.8% reading N8 or better. In the myopic group, mean SEQ was reduced from -4.52 ± 2.28 D preoperatively to +0.12 ± 0.49 D postoperatively in dominant eyes and to -1.04 ± 0.54 D in non-dominant eyes, with 96.8% of eyes within ±1.00 D of target. Binocularly, mean UDVA was -0.07 ± 0.09 logMAR with 87.1% of patients 20/20 or better at distance and 87.1% reading N8 or better.

Conclusions: PRESBYOND Laser Blended Vision was a safe and effective procedure for the treatment of myopic and hyperopic presbyopia.

查看原文本刊更多论文

近视和远视患者激光混合视力（PRESBYOND）后的视力和屈光效果。

目的：报道PRESBYOND激光混合视力（Carl Zeiss Meditec AG）采用非线性非球面轮廓结合微参差激光原位角膜磨圆术（LASIK）治疗近视和远视老花眼后的视力和屈光效果。方法：回顾性分析使用MEL-90准分子激光和VisuMax飞秒激光（卡尔蔡司Meditec AG）双眼接受PRESBYOND激光混合视力治疗的患者，并提供至少3个月的术后数据。优势眼的目标是平视，非优势眼的目标是-0.50和-1.50屈光度(D)之间的近视。测量明显屈光、单眼和双眼未矫正距离视力（UDVA）、单眼矫正距离视力（CDVA）和双眼未矫正近视力。结果：纳入116例患者232眼（远视170眼，近视眼62眼）。远视组中，优势眼平均球等效（SEQ）由术前+1.49±0.67 D降至术后-0.06±0.39 D，非优势眼平均SEQ降至-1.29±0.57 D， 96.5%的眼距目标值在±1.00 D以内。双眼平均UDVA为最小分辨角（logMAR）的-0.06±0.08对数，90.5%的患者在远处20/20或更好，98.8%的患者读数为N8或更好。近视组平均SEQ由术前的-4.52±2.28 D降至优势眼术后的+0.12±0.49 D，非优势眼术后的-1.04±0.54 D， 96.8%的眼在目标±1.00 D范围内。双眼平均UDVA为-0.07±0.09 logMAR， 87.1%的患者远视20/20或更好，87.1%的患者阅读N8或更好。结论：PRESBYOND激光混合视力是一种安全有效的治疗近视和远视老花眼的方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

$Journal of refractive surgery$

Journal of refractive surgery 医学-外科

CiteScore

5.10

自引率

12.50%

发文量

160

审稿时长

4-8 weeks

期刊介绍： The Journal of Refractive Surgery, the official journal of the International Society of Refractive Surgery, a partner of the American Academy of Ophthalmology, has been a monthly peer-reviewed forum for original research, review, and evaluation of refractive and lens-based surgical procedures for more than 30 years. Practical, clinically valuable articles provide readers with the most up-to-date information regarding advances in the field of refractive surgery. Begin to explore the Journal and all of its great benefits such as: • Columns including “Translational Science,” “Surgical Techniques,” and “Biomechanics” • Supplemental videos and materials available for many articles • Access to current articles, as well as several years of archived content • Articles posted online just 2 months after acceptance.